Content about Ciba Specialty Chemicals

February 17, 2011

Novartis names Naomi Kelman as new head of the Novartis OTC division

Novartis on Thursday morning named Naomi Kelman head of the Novartis OTC division, effective March 2. She will report directly to Joseph Jimenez, Novartis CEO.

December 15, 2010

Novartis positions itself as eye care giant with Alcon merger

Novartis on Wednesday announced that its merger agreement with Alcon has been settled to the tune of $12.9 billion. The new $8.7 billion Alcon eye care division, which includes CIBA Vision and selected ophthalmic medicines, will be led by current Alcon president and CEO Kevin Buehler.

January 3, 2010

Novartis announces merger proposal for Alcon

With an eye to the future, Novartis brass envisions a growth arena driven by the...